---
title: "EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days"
date: "2025-05-20T14:18:59.000Z"
publishedDate: "20 mai 2025"
summary: "Thirty-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneous coronary intervention (PCI) study in female patients with complex, calcified coronary artery disease have been presented at EuroPCR 2025 (20–23 May, Paris, France). The favourable results confirm earlier retrospective analyses demonstrating the benefits of coronary intravascular lithotripsy (IVL, Shockwave Medical) in female patients."
importance: ""
sourceUrl: "https://cardiovascularnews.com/europcr-2025-all-female-coronary-ivl-trial-reports-positive-outcomes-at-30-days/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-05-20-europcr-2025-all-female-coronary-ivl-trial-reports-positive-outcomes-at-30-days"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/05/McEntegart.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2025-all-female-coronary-ivl-trial-reports-positive-outcomes-at-30-days/"
---

![EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/05/McEntegart.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2025-all-female-coronary-ivl-trial-reports-positive-outcomes-at-30-days/*

## L’essentiel

Thirty-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneous coronary intervention (PCI) study in female patients with complex, calcified coronary artery disease have been presented at EuroPCR 2025 (20–23 May, Paris, France). The favourable results confirm earlier retrospective analyses demonstrating the benefits of coronary intravascular lithotripsy (IVL, Shockwave Medical) in female patients.

## Lien source

https://cardiovascularnews.com/europcr-2025-all-female-coronary-ivl-trial-reports-positive-outcomes-at-30-days/
